GB0118892D0 - Method of treatment - Google Patents

Method of treatment

Info

Publication number
GB0118892D0
GB0118892D0 GBGB0118892.9A GB0118892A GB0118892D0 GB 0118892 D0 GB0118892 D0 GB 0118892D0 GB 0118892 A GB0118892 A GB 0118892A GB 0118892 D0 GB0118892 D0 GB 0118892D0
Authority
GB
United Kingdom
Prior art keywords
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0118892.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis Research Ltd
Original Assignee
Vernalis Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vernalis Research Ltd filed Critical Vernalis Research Ltd
Priority to GBGB0118892.9A priority Critical patent/GB0118892D0/en
Publication of GB0118892D0 publication Critical patent/GB0118892D0/en
Priority to PCT/GB2002/003545 priority patent/WO2003011281A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
GBGB0118892.9A 2001-08-02 2001-08-02 Method of treatment Ceased GB0118892D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0118892.9A GB0118892D0 (en) 2001-08-02 2001-08-02 Method of treatment
PCT/GB2002/003545 WO2003011281A1 (en) 2001-08-02 2002-08-02 Treatment of attention deficit hyperactivity disorder or attention deficit disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0118892.9A GB0118892D0 (en) 2001-08-02 2001-08-02 Method of treatment

Publications (1)

Publication Number Publication Date
GB0118892D0 true GB0118892D0 (en) 2001-09-26

Family

ID=9919696

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0118892.9A Ceased GB0118892D0 (en) 2001-08-02 2001-08-02 Method of treatment

Country Status (2)

Country Link
GB (1) GB0118892D0 (en)
WO (1) WO2003011281A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5173190B2 (en) 2004-08-25 2013-03-27 武田薬品工業株式会社 Preventive and therapeutic agent for stress urinary incontinence and screening method thereof
WO2006028961A2 (en) * 2004-09-03 2006-03-16 Athersys, Inc. Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
WO2007132841A1 (en) 2006-05-16 2007-11-22 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
JP5520051B2 (en) 2007-11-15 2014-06-11 武田薬品工業株式会社 Condensed pyridine derivatives and uses thereof
EP2510949A4 (en) 2009-12-11 2013-11-13 Astellas Pharma Inc Therapeutic agent for fibromyalgia
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722194B1 (en) * 1994-07-06 1996-08-23 Adir NOVEL BENZOPYRANE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACUETIC COMPOSITIONS CONTAINING THEM
JP2002541098A (en) * 1999-04-06 2002-12-03 セプラコア インコーポレーテッド Methods and compositions for treating neuroleptic disorders and related disorders using ziprasidone metabolites
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane

Also Published As

Publication number Publication date
WO2003011281A1 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
GB2393202B (en) Methods of well treatment
GB0014969D0 (en) Novel method of treatment
GB0129976D0 (en) Treatment method
EP1389105A4 (en) Method of treatment
GB0124124D0 (en) Methods of treatment
GB0120147D0 (en) Treatment method
GB0112216D0 (en) Method of treatment
IL158004A0 (en) Method of enhancing entomophilous
GB0118892D0 (en) Method of treatment
GB0008921D0 (en) Method of treatment
GB0130763D0 (en) Treatment methods
AUPR731901A0 (en) Method of treatment
GB0208897D0 (en) New method of treatment
IL161630A0 (en) Methods of treating endometreosis
EP1303281A4 (en) Methods of treatment
NZ528896A (en) Treatment of ADHD
GB0126253D0 (en) Treatment method
GB0213198D0 (en) Method of treatment
GB0116029D0 (en) Method of treatment
GB0111487D0 (en) Method of treatment
GB0125105D0 (en) Method of treatment
GB0126094D0 (en) Method of treatment
GB0207091D0 (en) Method of treatment
GB0002762D0 (en) Method of treatment
GB0026742D0 (en) Novel method of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)